BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25019157)

  • 1. ACE and ACE2 in inflammation: a tale of two enzymes.
    Gaddam RR; Chambers S; Bhatia M
    Inflamm Allergy Drug Targets; 2014; 13(4):224-34. PubMed ID: 25019157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
    Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
    Santos RA; Ferreira AJ; Verano-Braga T; Bader M
    J Endocrinol; 2013 Feb; 216(2):R1-R17. PubMed ID: 23092879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the renin-angiotensin system in caerulein induced acute pancreatitis in the mouse.
    Gaddam RR; Ang AD; Badiei A; Chambers ST; Bhatia M
    Pancreatology; 2015; 15(6):647-53. PubMed ID: 26444748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
    Simões E Silva AC; Teixeira MM
    Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
    Keidar S; Kaplan M; Gamliel-Lazarovich A
    Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
    Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
    Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
    Moreira de Macêdo S; Guimarães TA; Feltenberger JD; Sousa Santos SH
    Peptides; 2014 Dec; 62():189-96. PubMed ID: 25453980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
    Ferreira AJ; Bader M; Santos RA
    Expert Opin Ther Pat; 2012 May; 22(5):567-74. PubMed ID: 22510001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.
    Rodrigues Prestes TR; Rocha NP; Miranda AS; Teixeira AL; Simoes-E-Silva AC
    Curr Drug Targets; 2017; 18(11):1301-1313. PubMed ID: 27469342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE2: a new target for cardiovascular disease therapeutics.
    Raizada MK; Ferreira AJ
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
    Zhuo JL; Li XC
    Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
    Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
    Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.
    Santos RA; Ferreira AJ; Simões E Silva AC
    Exp Physiol; 2008 May; 93(5):519-27. PubMed ID: 18310257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).
    Santos RAS; Sampaio WO; Alzamora AC; Motta-Santos D; Alenina N; Bader M; Campagnole-Santos MJ
    Physiol Rev; 2018 Jan; 98(1):505-553. PubMed ID: 29351514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
    Pernomian L; Pernomian L; Baraldi Araújo Restini C
    Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
    Lubel JS; Herath CB; Burrell LM; Angus PW
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1327-38. PubMed ID: 18557800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ACE2 in diastolic and systolic heart failure.
    Wang W; Bodiga S; Das SK; Lo J; Patel V; Oudit GY
    Heart Fail Rev; 2012 Sep; 17(4-5):683-91. PubMed ID: 21638102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated renin-angiotensin system contributes to acute lung injury caused by hind-limb ischemia-reperfusion in mice.
    Chen LN; Yang XH; Nissen DH; Chen YY; Wang LJ; Wang JH; Gao JL; Zhang LY
    Shock; 2013 Nov; 40(5):420-9. PubMed ID: 23903854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.